Court Sets Preliminary $15 Million Settlement in Allergan Subsidiary Antitrust Case

Drug Industry Daily
A A
A federal judge signed off on a $15 million settlement to close out claims of anticompetitive behavior by Allergan and its subsidiary Warner Chilcott.

To View This Article:

Login

Subscribe To Drug Industry Daily